Ajer Jeffrey Robert — SEC insider filings

SEC reporting owner CIK 1557533. 38 insider filings on record with FilingPulse; latest filed 2026-09-25.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2020-09-21 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)EVP, Chief Commercial Officer25—19 legs · 93,227 sh · $9,343,16929
NEKTAR THERAPEUTICS (NKTR)Director10—5 legs · 17,722 sh · $181,91512
Viridian Therapeutics, Inc.\DE (VRDN)Director3——3

Insider filings — Ajer Jeffrey Robert

FiledFormIssuerReported transactionsSource
2026-09-254NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 2,000 @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2026-07-024Viridian Therapeutics, Inc.\DE (VRDN)Grant/award (A): 32,341 (derivative) @ $0EDGAR
2025-10-014NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 8,000 (derivative) @ $0EDGAR
2025-07-024Viridian Therapeutics, Inc.\DE (VRDN)Grant/award (A): 21,000 (derivative) @ $0EDGAR
2025-04-094Viridian Therapeutics, Inc.\DE (VRDN)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2024-05-064BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 300 @ $68.65 · Sale (S): 5,000 @ $82.91EDGAR
2024-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 22,580 @ $83.87EDGAR
2024-03-074BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 4,000 @ $87.07EDGAR
2024-02-294BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 21,440 @ $0 · Grant/award (A): 9,338 @ $0 · Grant/award (A): 6,465 @ $0EDGAR
2023-09-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 4,359 @ $0.69 · Grant/award (A): 85,000 (derivative) @ $0EDGAR
2023-08-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 318 @ $66.88 · Sale (S): 5,000 @ $90EDGAR
2023-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 10,110 @ $0 · Tax withholding (F): 3,971 @ $87.74 · Tax withholding (F): 20,510 @ $93.41 · Grant/award (A): 23,070 (derivative) @ $0EDGAR
2023-03-024BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 20,760 @ $0 · Grant/award (A): 10,380 @ $0 · Grant/award (A): 7,629 @ $0EDGAR
2023-01-274BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 49,000 @ $67.81 · Sale (S): 44,825 @ $115.65 · Sale (S): 4,175 @ $116.15 · Option exercise (M): 2,200 (derivative) @ $0 · Option exercise (M): 46,800 (derivative) @ $0EDGAR
2022-11-044BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 3,000 @ $86.12EDGAR
2022-09-264NEKTAR THERAPEUTICS (NKTR)Sale (S): 4,198 @ $3.16EDGAR
2022-09-204NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 10,200 @ $0 · Grant/award (A): 20,400 (derivative) @ $0EDGAR
2022-08-124BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 3,000 @ $95.62EDGAR
2022-06-074BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 7,021 @ $77.49EDGAR
2022-05-314BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 340 @ $62.41 · Sale (S): 1,308 @ $78.94EDGAR
2022-04-144BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,180 @ $82.47EDGAR
2022-03-314BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,618 @ $79.43 · Sale (S): 1,381 @ $79.56EDGAR
2022-03-244BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 2,073 @ $81 · Sale (S): 6,129 @ $81.78EDGAR
2022-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 11,940 @ $0 · Tax withholding (F): 8,418 @ $78.27 · Tax withholding (F): 1,287 @ $80.72 · Grant/award (A): 28,670 (derivative) @ $0EDGAR
2022-03-104BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 9,370 @ $0EDGAR
2021-10-284BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 342 @ $62.41 · Sale (S): 2,739 @ $73.60EDGAR
2021-09-244NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 10,200 @ $0 · Sale (S): 3,665 @ $17.78 · Grant/award (A): 20,400 (derivative) @ $0EDGAR
2021-04-094BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,537 @ $78.81EDGAR
2021-04-014BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,652 @ $74.79EDGAR
2021-03-264BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,181 @ $76.30EDGAR
2021-03-234BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 1,513 @ $78.52EDGAR
2021-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,308 @ $77.99EDGAR
2021-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 10,720 @ $0 · Tax withholding (F): 5,273 @ $78.39 · Tax withholding (F): 1,287 @ $77.21 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2020-10-154BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 2,121 @ $79.91EDGAR
2020-09-304NEKTAR THERAPEUTICS (NKTR)Sale (S): 3,250 @ $17.25EDGAR
2020-09-254/ANEKTAR THERAPEUTICS (NKTR)Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0EDGAR
2020-09-244NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0EDGAR
2020-09-214NEKTAR THERAPEUTICS (NKTR)Sale (S): 2,250 @ $19.74EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557533 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs